Sanofi & Nia Health continue partnership
16.02.2023 15:14
Nia Health GmbH, the developer of the Nia app for managing atopic dermatitis, and the healthcare company Sanofi will continue and expand their collaboration. Sanofi has been a partner of Nia Health since the beginning of 2021 and was the first healthcare company to partner with the Charité spin-off.
Atopic dermatitis is the most common chronic skin disease, characterized by frequent flare-ups of inflammation, the course of which can be exacerbated by allergic reactions. It is accompanied by an intensely itchy rash and affects both children and adults.
Berlin-based digital health company Nia Health has developed the Nia app, the first digital medical device for patients with atopic dermatitis (eczema). Users can document their disease progression and identify flare-up triggers using scientifically based metrics. In addition, users receive background medical information about the condition to better understand and manage it. The app is the most widely used app for this indication and has already received several awards.
Digitalization in patient care is an enormously important step forward.
The collaboration between Nia Health GmbH and Sanofi, which has been in place since 2021, has now been extended for the second time. Markus Isenmann, Franchise Head Immunology at Sanofi, Sanofi, The company explains the continuation of the collaboration as follows: “Digitalization in patient care is an enormously important step forward. With this partnership, we want to help shape the future of patient care and create a new awareness of digital support services.”
Tobias Seidl, CEO and Co-Founder of Nia Health, adds: “We are delighted to continue having such a strong partner as Sanofi by our side. We share the same vision and are convinced that together we can help even more patients.”